facebook-page-view
Advertisement

Tracing Ascent Capital’s returns from partial exit in drug ingredients maker

By Ankit Doshi

  • 22 Oct 2020
Premium
Tracing Ascent Capital’s returns from partial exit in drug ingredients maker
Credit: 123RF.com

Homegrown private equity firm Ascent Capital appears to have scored neat returns from a partial exit in one of India’s topmost pharmaceutical ingredient makers in which it had invested through a fund of 2009 vintage. Ascent Capital has sold more than half its stake in Mumbai-listed Solara Active Pharma Sciences Ltd, ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement